Henry Schein (HSIC)

Nasdaq Health Care Health Care Distributors S&P 500
$86.05
+0.74 (+0.87%)
Close of Nov 06, 2026 · end-of-day data
Source: Henry Schein's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 04, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$11.57B$8.88B$9.42B$9.99B$10.12B$12.40B$12.65B$12.34B$12.67B$13.18B
Cost of revenue$8.35B$6.14B$6.51B$6.89B$7.30B$8.73B$8.82B$8.48B$8.66B$9.08B
Gross profit$3.23B$2.75B$2.91B$3.09B$2.82B$3.67B$3.83B$3.86B$4.02B$4.11B
Selling, general & admin$2.41B$2.07B$2.22B$2.36B$2.09B$2.63B$2.77B$2.96B$3.03B$3.08B
Operating income$771.57M$669.76M$600.62M$718.26M$535.00M$852.00M$747.00M$615.00M$621.00M$653.00M
Interest expense$31.89M$51.07M$76.02M$50.79M$41.00M$27.00M$35.00M$87.00M$131.00M$150.00M
Pre-tax income$755.84M$629.79M$536.84M$680.31M$500.00M$831.00M$721.00M$542.00M$513.00M$533.00M
Income tax$217.96M$308.98M$107.43M$159.51M$95.00M$198.00M$170.00M$120.00M$128.00M$126.00M
Net income$506.78M$406.30M$535.88M$694.73M$404.00M$631.00M$538.00M$416.00M$390.00M$398.00M
EBITDA$941.35M$803.62M$744.25M$903.20M$721.00M$1.06B$959.00M$863.00M$918.00M$964.00M
EPS (basic)$3.14$2.59$3.51$4.70$2.83$4.51$3.95$3.18$3.07$3.29
EPS (diluted)$3.10$2.57$3.49$4.65$2.82$4.45$3.91$3.16$3.05$3.27
Diluted shares163.72M158.21M153.71M149.26M143.40M141.77M137.76M131.75M127.78M121.72M
Gross margin27.9%30.9%30.9%31.0%27.8%29.6%30.3%31.3%31.7%31.1%
Operating margin6.7%7.5%6.4%7.2%5.3%6.9%5.9%5.0%4.9%5.0%
Net margin4.4%4.6%5.7%7.0%4.0%5.1%4.3%3.4%3.1%3.0%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$62.38M$158.00M$56.88M$106.10M$421.00M$118.00M$117.00M$171.00M$122.00M$156.00M
Receivables$1.25B$1.52B$1.17B$1.25B$1.42B$1.45B$1.44B$1.86B$1.48B$1.65B
Inventory$1.67B$1.93B$1.42B$1.43B$1.51B$1.86B$1.96B$1.81B$1.81B$2.00B
Total current assets$3.34B$4.09B$4.18B$3.23B$3.79B$3.84B$3.99B$4.49B$3.98B$4.46B
Goodwill$2.02B$1.55B$2.08B$2.46B$2.50B$2.85B$2.89B$3.88B$3.89B$4.21B
Total assets$6.81B$7.86B$8.50B$7.15B$7.77B$8.48B$8.61B$10.57B$10.22B$11.21B
Total current liabilities$2.32B$2.83B$3.22B$2.04B$2.28B$2.31B$2.22B$2.68B$2.80B$3.23B
Short-term debt$65.92M$16.66M$951.46M$23.98M$73.37M$51.00M$103.00M$264.00M$650.00M$764.00M
Long-term debt$715.46M$907.76M$980.34M$622.91M$515.77M$822.00M$1.05B$1.94B$1.83B$2.31B
Total debt$781.38M$924.41M$1.93B$646.88M$589.14M$873.00M$1.15B$2.20B$2.48B$3.07B
Total liabilities$3.35B$4.21B$4.65B$3.23B$3.46B$3.81B$3.94B$5.42B$5.38B$6.42B
Shareholders' equity$2.79B$2.81B$2.96B$3.00B$3.35B$3.42B$3.45B$3.65B$3.39B$3.25B

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$642.58M$545.51M$684.71M$654.09M$599.00M$710.00M$602.00M$500.00M$848.00M$712.00M
Capital expenditures$70.18M$62.40M$71.28M$76.22M$49.00M$79.00M$96.00M$147.00M$148.00M$139.00M
Free cash flow$572.40M$483.11M$613.42M$577.87M$550.00M$631.00M$506.00M$353.00M$700.00M$573.00M
Investing cash flow-$316.42M-$342.28M-$192.95M-$424.37M-$115.00M-$677.00M-$276.00M-$1.14B-$430.00M-$400.00M
Financing cash flow-$327.34M-$112.55M-$603.78M-$215.98M-$187.00M-$333.00M-$315.00M$701.00M-$510.00M-$188.00M
Share buybacks$550.02M$450.00M$200.00M$525.00M$74.00M$401.00M$485.00M$250.00M$385.00M$850.00M
Stock-based compensation$58.25M$36.84M$32.62M$44.92M$9.00M$78.00M$54.00M$39.00M$39.00M$39.00M
Depreciation & amortization$169.78M$133.85M$143.63M$184.94M$186.00M$210.00M$212.00M$248.00M$297.00M$311.00M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.